Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-018518
Filing Date
2025-06-30
Accepted
2025-06-30 17:00:06
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 form4-06302025_050601.html 4  
1 form4-06302025_050601.xml 4 4068
  Complete submission text file 0001415889-25-018518.txt   5526
Mailing Address C/O SCPHARMACEUTICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address
Agger Mette Kirstine (Reporting) CIK: 0001722234 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 251092917

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)